adjuvant chemotherapy in cancer of thelarge bowelthe completeness of reporting, the avail-ability of continuous statistical analysis towarn of adverse effects, and the accumulationof 300 cases a year have demonstrated that thiscooperative study group can provide a rela-tively quick assessment of a new approach totreatment of cancer of the large bowel.  it ishoped that a study begun in january, 1962, onthe use of 5-fluorodeoxyuridine as an adjuvantto adequate excisional surgery may demon-strate that, with a drug known to produceobjective remissions in 20 per cent of a groupof unresectable cases of colon carcinomathe five year survival rate in curative resectionsmay be improved.